DK3585891T3 - Fremgangsmåder til oprensning af messenger-rna - Google Patents
Fremgangsmåder til oprensning af messenger-rna Download PDFInfo
- Publication number
- DK3585891T3 DK3585891T3 DK18711201.6T DK18711201T DK3585891T3 DK 3585891 T3 DK3585891 T3 DK 3585891T3 DK 18711201 T DK18711201 T DK 18711201T DK 3585891 T3 DK3585891 T3 DK 3585891T3
- Authority
- DK
- Denmark
- Prior art keywords
- purification
- methods
- messenger rna
- messenger
- rna
- Prior art date
Links
- 108020004999 messenger RNA Proteins 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/028—Modular arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/16—Reagents, handling or storing thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0409—Moving fluids with specific forces or mechanical means specific forces centrifugal forces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/113—Denaturating agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/30—Characterised by physical treatment
- C12Q2523/308—Adsorption or desorption
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y201/00—Transferases transferring one-carbon groups (2.1)
- C12Y201/03—Carboxy- and carbamoyltransferases (2.1.3)
- C12Y201/03003—Ornithine carbamoyltransferase (2.1.3.3)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762463998P | 2017-02-27 | 2017-02-27 | |
PCT/US2018/019954 WO2018157133A1 (en) | 2017-02-27 | 2018-02-27 | Methods for purification of messenger rna |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3585891T3 true DK3585891T3 (da) | 2021-11-22 |
Family
ID=61628474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18711201.6T DK3585891T3 (da) | 2017-02-27 | 2018-02-27 | Fremgangsmåder til oprensning af messenger-rna |
Country Status (11)
Country | Link |
---|---|
US (2) | US10808241B2 (da) |
EP (2) | EP3971291A1 (da) |
AU (1) | AU2018224843A1 (da) |
CA (1) | CA3054321A1 (da) |
CY (1) | CY1124735T1 (da) |
DK (1) | DK3585891T3 (da) |
ES (1) | ES2899323T3 (da) |
HU (1) | HUE059025T2 (da) |
IL (1) | IL268857B1 (da) |
MA (1) | MA47605A (da) |
WO (1) | WO2018157133A1 (da) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2838063C (en) | 2011-06-08 | 2023-07-11 | Shire Human Genetic Therapies, Inc. | Cleavable lipids |
WO2014152966A1 (en) | 2013-03-14 | 2014-09-25 | Shire Human Genetic Therapies, Inc. | Methods for purification of messenger rna |
WO2018157133A1 (en) * | 2017-02-27 | 2018-08-30 | Translate Bio, Inc. | Methods for purification of messenger rna |
MA50803A (fr) | 2017-11-22 | 2020-09-30 | Modernatx Inc | Polynucléotides codant pour l'ornithine transcarbamylase pour le traitement de troubles du cycle de l'urée |
US20210220449A1 (en) * | 2018-05-15 | 2021-07-22 | Translate Bio, Inc. | Subcutaneous Delivery of Messenger RNA |
CN112930396B (zh) | 2018-08-24 | 2024-05-24 | 川斯勒佰尔公司 | 用于纯化信使rna的方法 |
US20210388338A1 (en) * | 2018-11-08 | 2021-12-16 | Translate Bio, Inc. | Methods and Compositions for Messenger RNA Purification |
BR112021014966A2 (pt) | 2019-02-11 | 2021-10-05 | Ethris Gmbh | Métodos para purificar moléculas de mrna e para produzir uma composição farmacêutica |
MX2021013954A (es) * | 2019-05-15 | 2022-03-11 | Translate Bio Inc | Métodos de purificación de arn mensajero. |
CA3162368A1 (en) | 2019-12-20 | 2021-06-24 | Shrirang KARVE | Rectal delivery of messenger rna |
CN115461042A (zh) | 2019-12-20 | 2022-12-09 | 翻译生物公司 | 制备负载mrna的脂质纳米颗粒的改进方法 |
WO2021163134A1 (en) | 2020-02-10 | 2021-08-19 | Translate Bio, Inc. | Methods and compositions for messenger rna purification |
EP4110296A1 (en) | 2020-02-25 | 2023-01-04 | Translate Bio, Inc. | Improved processes of preparing mrna-loaded lipid nanoparticles |
WO2021226463A1 (en) | 2020-05-07 | 2021-11-11 | Translate Bio, Inc. | Composition and methods for treatment of primary ciliary dyskinesia |
WO2021226436A1 (en) | 2020-05-07 | 2021-11-11 | Translate Bio, Inc. | Optimized nucleotide sequences encoding sars-cov-2 antigens |
AU2021273502A1 (en) | 2020-05-15 | 2023-02-02 | Translate Bio, Inc. | Lipid nanoparticle formulations for mRNA delivery |
JP2023544167A (ja) * | 2020-10-01 | 2023-10-20 | トランスレイト バイオ, インコーポレイテッド | メッセンジャーrnaの精製のための方法 |
CN116546976A (zh) | 2020-10-06 | 2023-08-04 | 翻译生物公司 | 脂质纳米颗粒的改进工艺和配制 |
WO2022081548A1 (en) | 2020-10-12 | 2022-04-21 | Translate Bio, Inc. | Improved process of preparing ice-based lipid nanoparticles |
KR20230087536A (ko) | 2020-10-12 | 2023-06-16 | 트랜슬레이트 바이오 인코포레이티드 | Mrna-로딩된 지질 나노입자를 제조하는 개선된 프로세스 |
EP4313115A1 (en) | 2021-03-25 | 2024-02-07 | Translate Bio, Inc. | Optimized nucleotide sequences encoding the extracellular domain of human ace2 protein or a portion thereof |
WO2022225918A1 (en) | 2021-04-19 | 2022-10-27 | Translate Bio, Inc. | Improved compositions for delivery of mrna |
CN117881395A (zh) | 2021-07-01 | 2024-04-12 | 翻译生物公司 | 用于递送mRNA的组合物 |
WO2023086893A1 (en) | 2021-11-10 | 2023-05-19 | Translate Bio, Inc. | Composition and methods for treatment of primary ciliary dyskinesia |
WO2024083345A1 (en) | 2022-10-21 | 2024-04-25 | BioNTech SE | Methods and uses associated with liquid compositions |
WO2024112652A1 (en) | 2022-11-21 | 2024-05-30 | Translate Bio, Inc. | Compositions of dry powder formulations of messenger rna and methods of use thereof |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
US5139667A (en) | 1988-12-20 | 1992-08-18 | Sparkler Filters, Inc. | Nutsche process filter drive unit |
US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
US5544425A (en) | 1995-05-17 | 1996-08-13 | Mallinckrodt Medical, Inc. | Aggressive convective drying in a nutsche type filter/dryer |
US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
JP3930616B2 (ja) | 1997-08-25 | 2007-06-13 | 住友化学株式会社 | 2−アミノ−6置換プリンの精製方法 |
DE19917558C2 (de) | 1999-04-19 | 2003-05-08 | Joachim Schwindling | Filtrationsapparat |
EP1390414B1 (de) | 2001-05-14 | 2006-08-30 | Polytag Technology SA | Verfahren zur abtrennung von reversibel thermopräzipitierbaren oligomeren n-substituierter (meth)acrylamidverbindungen und deren konjugate |
DE10131107A1 (de) | 2001-06-27 | 2003-01-09 | Mann & Hummel Filter | Filtervorrichtung bzw. schwenkbares Filtermedium für diese Filtervorrichtung |
JP2004167345A (ja) | 2002-11-19 | 2004-06-17 | Sumitomo Chem Co Ltd | 固体粒子の洗浄方法 |
US7267950B2 (en) * | 2003-05-01 | 2007-09-11 | Veridex, Lcc | Rapid extraction of RNA from cells and tissues |
JP4663631B2 (ja) | 2004-04-28 | 2011-04-06 | 天野エンザイム株式会社 | 放線菌由来のampデアミナーゼ及びその利用 |
US7473511B2 (en) * | 2004-12-15 | 2009-01-06 | Fuji Xerox Co., Ltd. | Particle dispersion for electrostatic image-developing toners, electrostatic image-developing toner, and method for producing the same |
US7494794B2 (en) | 2006-03-31 | 2009-02-24 | Toyo Boseki Kabushiki Kaisha | Glucose dehydrogenase |
WO2008078646A1 (ja) | 2006-12-22 | 2008-07-03 | Ajinomoto Co., Inc. | アミノ酸又は核酸の結晶の分離方法 |
US20090065435A1 (en) | 2007-09-10 | 2009-03-12 | Powell Intellectual Property Holdings, Llc | Modified Biogenic Silica and Method for Purifying a Liquid |
US20090148384A1 (en) | 2007-12-10 | 2009-06-11 | Fischer Katrin | Functionalized, solid polymer nanoparticles comprising epothilones |
NZ588408A (en) | 2008-04-16 | 2012-05-25 | Biogen Idec Inc | Method of isolating proteins using polyethylene glycol and zinc |
MX353900B (es) | 2008-11-07 | 2018-02-01 | Massachusetts Inst Technology | Lipidoides de aminoalcohol y usos de los mismos. |
US20130059008A1 (en) * | 2009-01-23 | 2013-03-07 | Jeffrey L. Atkinson | Drying methods for tuning microparticle properties |
US20120165500A1 (en) | 2009-08-27 | 2012-06-28 | Newlight Technologies, Llc | Process for the production of polyhydroxyalkanoates |
US8326547B2 (en) | 2009-10-07 | 2012-12-04 | Nanjingjinsirui Science & Technology Biology Corp. | Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm |
EP3318248B1 (en) * | 2009-12-01 | 2019-04-10 | Translate Bio, Inc. | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
WO2012075040A2 (en) | 2010-11-30 | 2012-06-07 | Shire Human Genetic Therapies, Inc. | mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES |
CA2838063C (en) | 2011-06-08 | 2023-07-11 | Shire Human Genetic Therapies, Inc. | Cleavable lipids |
NZ719345A (en) | 2011-06-08 | 2023-03-31 | Translate Bio Inc | Lipid nanoparticle compositions and methods for mrna delivery |
AU2012286901B2 (en) * | 2011-07-25 | 2016-10-27 | Sangamo Therapeutics, Inc. | Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene |
MX363734B (es) | 2011-10-27 | 2019-03-29 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco. |
JP6211054B2 (ja) | 2012-03-29 | 2017-10-11 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | 脂質誘導される中性ナノ粒子 |
JP6283655B2 (ja) | 2012-03-29 | 2018-02-21 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | イオン化可能なカチオン性脂質 |
EP2859102A4 (en) | 2012-06-08 | 2016-05-11 | Shire Human Genetic Therapies | NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF |
ES2864878T3 (es) | 2012-06-08 | 2021-10-14 | Translate Bio Inc | Administración pulmonar de ARN, a células objetivo no pulmonares |
ES2968649T3 (es) | 2012-12-07 | 2024-05-13 | Translate Bio Inc | Nanopartículas lipídicas para la administración de ARNm en los pulmones |
WO2014152940A1 (en) | 2013-03-14 | 2014-09-25 | Shire Human Genetic Therapies, Inc. | Mrna therapeutic compositions and use to treat diseases and disorders |
WO2014152966A1 (en) | 2013-03-14 | 2014-09-25 | Shire Human Genetic Therapies, Inc. | Methods for purification of messenger rna |
AU2014239250A1 (en) | 2013-03-14 | 2015-08-27 | Shire Human Genetic Therapies, Inc. | Quantitative assessment for cap efficiency of messenger RNA |
JP2016515216A (ja) | 2013-03-14 | 2016-05-26 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | メッセンジャーrnaのキャップ効率の定量的評価 |
JP6399560B2 (ja) | 2013-03-14 | 2018-10-03 | トランスレイト バイオ, インコーポレイテッド | mRNAによってコードされる抗体を送達するための方法及び組成物 |
PL2968586T3 (pl) | 2013-03-14 | 2019-01-31 | Translate Bio, Inc. | Kompozycje mrna cftr i związne z nimi sposoby i zastosowania |
EP3750903A1 (en) | 2013-03-14 | 2020-12-16 | Translate Bio, Inc. | Ribonucleic acids with 4'-thio-modified nucleotides and related methods |
LT2970948T (lt) | 2013-03-15 | 2019-03-25 | Glaxosmithkline Biologicals Sa | Rna gryninimo būdai |
CN112656954A (zh) | 2013-10-22 | 2021-04-16 | 夏尔人类遗传性治疗公司 | 用于递送信使rna的脂质制剂 |
WO2015061500A1 (en) | 2013-10-22 | 2015-04-30 | Shire Human Genetic Therapies, Inc. | Mrna therapy for argininosuccinate synthetase deficiency |
CN105658242A (zh) | 2013-10-22 | 2016-06-08 | 夏尔人类遗传性治疗公司 | 用于苯丙酮尿症的mrna疗法 |
EP4036241A1 (en) | 2013-10-22 | 2022-08-03 | Translate Bio, Inc. | Cns delivery of mrna and uses thereof |
EP3122878B1 (en) | 2014-03-24 | 2018-10-24 | Translate Bio, Inc. | Mrna therapy for the treatment of ocular diseases |
WO2015164773A1 (en) | 2014-04-25 | 2015-10-29 | Shire Human Genetic Therapies, Inc. | Methods for purification of messenger rna |
WO2015184256A2 (en) | 2014-05-30 | 2015-12-03 | Shire Human Genetic Therapies, Inc. | Biodegradable lipids for delivery of nucleic acids |
EP3160959B1 (en) | 2014-06-24 | 2023-08-30 | Translate Bio, Inc. | Stereochemically enriched compositions for delivery of nucleic acids |
EP3164112A1 (en) | 2014-07-02 | 2017-05-10 | Shire Human Genetic Therapies, Inc. | Encapsulation of messenger rna |
EP3900702A1 (en) | 2015-03-19 | 2021-10-27 | Translate Bio, Inc. | Mrna therapy for pompe disease |
KR101693166B1 (ko) | 2016-07-12 | 2017-01-06 | 정수영 | 분말 액체 혼합물용 누체 여과 건조 장치 |
WO2018157133A1 (en) * | 2017-02-27 | 2018-08-30 | Translate Bio, Inc. | Methods for purification of messenger rna |
JP7256824B2 (ja) | 2018-04-25 | 2023-04-12 | エスリス ゲーエムベーハー | 粒子状製剤用の凍結保護剤 |
-
2018
- 2018-02-27 WO PCT/US2018/019954 patent/WO2018157133A1/en active Application Filing
- 2018-02-27 EP EP21204742.7A patent/EP3971291A1/en active Pending
- 2018-02-27 DK DK18711201.6T patent/DK3585891T3/da active
- 2018-02-27 CA CA3054321A patent/CA3054321A1/en active Pending
- 2018-02-27 HU HUE18711201A patent/HUE059025T2/hu unknown
- 2018-02-27 EP EP18711201.6A patent/EP3585891B1/en active Active
- 2018-02-27 ES ES18711201T patent/ES2899323T3/es active Active
- 2018-02-27 IL IL268857A patent/IL268857B1/en unknown
- 2018-02-27 AU AU2018224843A patent/AU2018224843A1/en active Pending
- 2018-02-27 US US15/906,864 patent/US10808241B2/en active Active
- 2018-02-27 MA MA047605A patent/MA47605A/fr unknown
-
2020
- 2020-10-14 US US17/070,877 patent/US11976272B2/en active Active
-
2021
- 2021-11-18 CY CY20211101004T patent/CY1124735T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
MA47605A (fr) | 2020-01-01 |
EP3585891A1 (en) | 2020-01-01 |
IL268857B1 (en) | 2024-05-01 |
US11976272B2 (en) | 2024-05-07 |
ES2899323T3 (es) | 2022-03-10 |
IL268857A (en) | 2019-10-31 |
US10808241B2 (en) | 2020-10-20 |
AU2018224843A1 (en) | 2019-09-19 |
CA3054321A1 (en) | 2018-08-30 |
US20210123041A1 (en) | 2021-04-29 |
WO2018157133A1 (en) | 2018-08-30 |
CY1124735T1 (el) | 2022-07-22 |
EP3585891B1 (en) | 2021-10-27 |
HUE059025T2 (hu) | 2022-10-28 |
EP3971291A1 (en) | 2022-03-23 |
US20180251755A1 (en) | 2018-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3585892T3 (da) | Fremgangsmåder til oprensning af messenger-rna | |
DK3585891T3 (da) | Fremgangsmåder til oprensning af messenger-rna | |
DK3585886T3 (da) | Storskalasyntese af messenger-rna | |
DK4140491T3 (da) | Fremgangsmåde til syntetisering af RNA'er med 5'-kappe | |
DK3445850T3 (da) | Fremgangsmåder til tilvejebringelse af enkeltstrenget rna | |
IL247973A0 (en) | Methods for purifying messenger RNA | |
DK3467108T3 (da) | Fremgangsmåder til oprensning af messenger-RNA | |
DK3377059T3 (da) | Hæmmere af cxcr2 | |
DK3337902T3 (da) | 3'-utr-sekvenser til stabilisering af rna | |
DK3292134T3 (da) | Metode til dyrkning af akkermansia | |
DK3294885T3 (da) | Fremgangsmåde til at fremstille rna | |
DK3394009T3 (da) | Genvinding af phosphorforbindelser fra spildevand | |
DK3463483T3 (da) | Behandling af primær ciliedyskinesi med syntetisk messenger-RNA | |
DK2964315T3 (da) | System til behandling af neuromotorisk dysfunktion | |
DK3201361T3 (da) | Fremgangsmåder til kvantificering af cellefrit DNA | |
DK3113858T3 (da) | Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater | |
DK3609529T3 (da) | Rna til behandling af autoimmune sygdomme | |
DK3288405T3 (da) | Kemisk minimeret system til tidsreduceret påsætning af øjenvippeforlængelser | |
DK3510042T3 (da) | Fremgangsmåde til rensning af antistoffer | |
DK3607068T3 (da) | RNA-interferensmedieret inhibering af TMPRSS6 | |
DK3458100T3 (da) | Selektiv reduktion af cystein-manipulerede antistoffer | |
DK3680000T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
ES2973282T3 (es) | Método de purificación | |
DK3356386T3 (da) | Fremgangsmåde til behandling af melanocortin-4 receptorbane-associerede lidelser | |
DK3400099T3 (da) | Fremgangsmåde til methanolsyntese under anvendelse af en indiumoxidbaseret katalysator |